Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matrix Health Group was a leading U.S. specialty pharmacy provider focused on patients with blood disorders and other complex chronic conditions. It merged with BiologicTx to form BioMatrix in 2015. The combined entity became one of the largest independent specialty infusion pharmacies in the U.S., serving patients with hemophilia, vWD, organ transplants, and other rare or complex diseases through a network of seven pharmacies nationwide. The business has since been acquired by private equity firms including Acon Investments and later Frazier Healthcare Partners.[6]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Matrix Health Group.